查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1489208

全球凝血检测市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Coagulation Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

全球凝血检测市场需求预计将从2023年的28.2亿美元达到2032年近52.3亿美元的市场规模，2024-2034年研究期间复合年增长率为7.11%。

凝血测试是评估血液凝块能力的诊断过程。它包括测量凝血因子、血小板功能和整体凝血级联的各种实验室检查。这些检查有助于诊断和监测出血性疾病、血栓形成和肝病等疾病。常见的检查包括凝血酶原时间 (PT)、活化部分凝血活酶时间 (aPTT)、国际标准化比值 (INR) 和凝血酶时间 (TT)。这些测试的结果为医疗保健提供者提供了宝贵的信息，用于管理抗凝血治疗、评估手术前出血风险以及诊断凝血障碍，有助于实现最佳的患者护理和治疗结果。

市场动态

血友病、血栓形成倾向和血管性血友病等凝血障碍的盛行率不断增加，加上心血管疾病、糖尿病和癌症的发生率不断上升，正在推动凝血检测作为疾病诊断、监测和管理的重要组成部分的需求。随着医疗保健提供者努力改善患者护理和结果，凝血测试对于评估出血和凝血障碍、指导治疗决策以及预防血栓形成和出血等併发症至关重要。此外，随着技术进步，医疗保健的未来看起来充满希望，包括即时护理(POC) 设备、实验室分析仪和分子检测，这些技术正在扩大医疗机构、诊所和实验室获得准确、及时的检测解决方案的机会全世界。

此外，个人化医疗方法和标靶治疗的日益普及推动了对凝血检测分析的需求，以提供快速、准确的结果来指导个人化治疗策略，从而推动市场成长。此外，对预防性医疗保健、健康筛检和早期干预策略的日益重视正在推动将这些测试整合到常规健康评估和健康计划中，从而推动市场扩张。然而，替代诊断方法的进步和医疗保健法规的变化可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球凝血测试市场的各个细分市场进行了包容性评估。凝血测试产业的成长和趋势为本研究提供了整体方法。

市场区隔

凝血测试市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依产品类型

  • 仪器
  • 耗材

按测试类型

  • 凝血酶原时间 (PT)
  • 活化部分凝血活酶凝血时间 (APTT)
  • 凝血酶时间 (TT)
  • 活化凝血时间 (ACT)
  • 其他的

按最终用户

  • 医院和诊所
  • 诊断实验室
  • 家庭护理设置
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲凝血测试市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。凝血测试市场的主要参与者包括 F. Hoffmann-La Roche Ltd.、Abbott、Siemens Healthineers、Sysmex Corporation、Universal Biosensors Inc.、HemoSonics LLC、Thermo Fisher Scientific Inc.、Randox Laboratories Ltd.、Horiba Ltd.、Appeppe Diagnostics Ltd.、Medtronic、Helena Laboratories Inc. 本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布，以及其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：混凝测试 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按产品类型
    • 按测试类型进行的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球凝血测试市场分析：依产品类型

  • 概述：按产品类型
  • 历史和预测数据
  • 分析：依产品类型
  • 仪器
  • 耗材

第 6 章：全球凝血测试市场分析：按测试类型

  • 按测试类型概述
  • 历史和预测数据
  • 按测试类型分析
  • 凝血酶原时间 (PT)
  • 活化部分凝血活酶凝血时间 (APTT)
  • 凝血酶时间 (TT)
  • 活化凝血时间 (ACT)
  • 其他的

第 7 章：全球凝血测试市场分析：依最终使用者分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院和诊所
  • 诊断实验室
  • 家庭护理设置
  • 其他的

第 8 章：全球凝血测试市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：凝血测试公司的竞争格局

  • 凝血检测市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Siemens Healthineers
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sysmex Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Universal Biosensors Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • HemoSonics LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Randox Laboratories Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Horiba Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Agappe Diagnostics Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medtronic
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Helena Laboratories Inc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114528

The global demand for Coagulation Testing Market is presumed to reach the market size of nearly USD 5.23 Billion by 2032 from USD 2.82 Billion in 2023 with a CAGR of 7.11% under the study period 2024-2034.

Coagulation testing is a diagnostic process assessing the blood's clot ability. It includes various laboratory tests that measure the clotting factors, platelet function, and overall coagulation cascade. These tests help diagnose and monitor conditions such as bleeding disorders, thrombosis, and liver disease. Common tests include prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), and thrombin time (TT). Results from these tests provide valuable information to healthcare providers for managing anticoagulant therapy, evaluating bleeding risks before surgery, and diagnosing coagulation disorders, contributing to optimal patient care and treatment outcomes.

MARKET DYNAMICS

The increasing prevalence of coagulation disorders such as hemophilia, thrombophilia, and von Willebrand disease, coupled with the spurring incidence of cardiovascular diseases, diabetes, and cancer, is driving demand for coagulation testing as a critical component of disease diagnosis, monitoring, and management. As healthcare providers strive to improve patient care & outcomes, coagulation testing is crucial in assessing bleeding and clotting disorders, guiding treatment decisions, and preventing complications such as thrombosis and hemorrhage. Moreover, the future of healthcare looks promising with technological advancements, including point-of-care (POC) devices, laboratory-based analyzers, and molecular assays, that are expanding access to accurate and timely testing solutions for healthcare facilities, clinics, and laboratories worldwide.

Furthermore, the increasing adoption of personalized medicine approaches and targeted therapies drives demand for coagulation testing assays to provide rapid and precise results to guide individualized treatment strategies, driving market growth. Moreover, the growing emphasis on preventive healthcare, wellness screenings, and early intervention strategies is driving the integration of these tests into routine health assessments and wellness programs, driving market expansion. However, advancements in alternative diagnostic methods and changes in healthcare regulations may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Coagulation Testing. The growth and trends of Coagulation Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Coagulation Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Instruments
  • Consumables

By Test Type

  • Prothrombin Time (PT)
  • Activated Partial Thromboplastin Clotting Time (APTT)
  • Thrombin Time (TT)
  • Activated Clotting Time (ACT)
  • Others

By End-user

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Coagulation Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Coagulation Testing market include F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, Sysmex Corporation, Universal Biosensors Inc., HemoSonics LLC, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Horiba Ltd., Agappe Diagnostics Ltd., Medtronic, Helena Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. COAGULATION TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Test Type
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product Type
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Consumables Historic and Forecast Sales By Regions

6. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY TEST TYPE

  • 6.1. Overview By Test Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Test Type
  • 6.4. Prothrombin Time (PT) Historic and Forecast Sales By Regions
  • 6.5. Activated Partial Thromboplastin Clotting Time (APTT) Historic and Forecast Sales By Regions
  • 6.6. Thrombin Time (TT) Historic and Forecast Sales By Regions
  • 6.7. Activated Clotting Time (ACT) Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End-user
  • 7.4. Hospitals and Clinics Historic and Forecast Sales By Regions
  • 7.5. Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 7.6. Home Care Settings Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE COAGULATION TESTING COMPANIES

  • 9.1. Coagulation Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF COAGULATION TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. F. Hoffmann-La Roche Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Abbott
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Siemens Healthineers
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Sysmex Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Universal Biosensors Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. HemoSonics LLC
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Thermo Fisher Scientific Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Randox Laboratories Ltd.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Horiba Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Agappe Diagnostics Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Medtronic
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Helena Laboratories Inc
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Analysis By Test Type (USD MN)
  • Prothrombin Time (PT) Market Sales By Geography (USD MN)
  • Activated Partial Thromboplastin Clotting Time (APTT) Market Sales By Geography (USD MN)
  • Thrombin Time (TT) Market Sales By Geography (USD MN)
  • Activated Clotting Time (ACT) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Coagulation Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Coagulation Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Coagulation Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Global Market Analysis By Test Type (USD MN)
  • Prothrombin Time (PT) Market Sales By Geography (USD MN)
  • Activated Partial Thromboplastin Clotting Time (APTT) Market Sales By Geography (USD MN)
  • Thrombin Time (TT) Market Sales By Geography (USD MN)
  • Activated Clotting Time (ACT) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.